Related Experiment Video
Updated: Feb 8, 2026

Hierarchical and Programmable One-Pot Oligosaccharide Synthesis
Published on: September 6, 2019
Heparin Oligosaccharides Have Antiarrhythmic Effect by Accelerating the Sodium-Calcium Exchanger
Carlos M G de Godoy1, Ênio R Vasques2,3, Afonso Caricati-Neto4
1Institute of Science and Technology, Universidade Federal de São Paulo, São Paulo, Brazil.
Insights
Heparin oligosaccharides, like trisulfated heparin disaccharide (TD), show antiarrhythmic effects by accelerating the Na+/Ca2+ exchanger (NCX) activity. These compounds prevent calcium overload-induced arrhythmias and reduce mortality in heart conditions.
Area of Science:
- Cardiovascular Pharmacology
- Cardiac Electrophysiology
- Drug Discovery
Background:
- The Na+/Ca2+ exchanger (NCX) plays a crucial role in cardiac rhythm regulation.
- Blocking NCX is a method to study its involvement in arrhythmogenesis.
- Heparin derivatives, such as trisulfated heparin disaccharide (TD) and Low Molecular Weight Heparins (LMWHs), can modulate NCX activity.
Purpose of the Study:
- To investigate the antiarrhythmic potential of heparin oligosaccharides.
- To elucidate the mechanism of action of these compounds on NCX activity.
- To evaluate their efficacy in preventing and treating cardiac arrhythmias.
Main Methods:
- Patch-clamp electrophysiology to measure NCX current in rat cardiomyocytes.
- Assessment of intracellular calcium transients.
- Induction and evaluation of arrhythmias in isolated rat atria and in vivo rat models.
- Pharmacological inhibition of NCX using KB-R7943.
Main Results:
- Enoxaparin and ardeparin reduced intracellular Ca2+ concentration and abolished arrhythmia induction in isolated atria.
- The antiarrhythmic effects of enoxaparin and ardeparin were reversed by the NCX antagonist KB-R7943.
- In vivo, TD administration significantly prevented reperfusion-induced arrhythmias and reduced mortality.
- Mechanistically, TD was shown to increase the forward mode NCX current.
Conclusions:
- Heparin oligosaccharides exhibit significant antiarrhythmic properties.
- Their mechanism involves accelerating the forward mode of the Na+/Ca2+ exchanger during calcium overload.
- These findings suggest heparin oligosaccharides represent a novel class of antiarrhythmic agents.
Abstract:
Background: Blockage of the Na+/Ca2+ exchanger (NCX) is used to determine the role of NCX in arrhythmogenesis. Trisulfated heparin disaccharide (TD) and Low Molecular Weight Heparins (LMWHs) can directly interact with the NCX and accelerate its activity. Objective: In this work, we investigated the antiarrhythmic effect of heparin oligosaccharides related to the NCX activity. Methods: The effects of heparin oligosaccharides were tested on the NCX current (patch clamping) and intracellular calcium transient in rat cardiomyocytes. The effects of heparin oligosaccharides were further investigated in arrhythmia induced in isolated rat atria and rats in vivo. Results: The intracellular Ca2+ concentration decreases upon treatment with either enoxaparin or ardeparin. These drugs abolished arrhythmia induction in isolated atria. The NCX antagonist KB-R7943 abolished the enoxaparin or ardeparin antiarrhythmic effects in isolated atria. In the in vivo measurements, injection of TD 15 min both before coronary occlusion or immediately after reperfusion, significantly prevented the occurrence of reperfusion-induced arrhythmias (ventricular arrhythmia and total AV block) and reduced the lethality rate. The patch clamping experiments showed that, mechanistically, TD increases the forward mode NCX current. Conclusion: Together, the data shows that heparin oligosaccharides may constitute a new class of antiarrhythmic drug that acts by accelerating the forward mode NCX under calcium overload.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Social Exchange Theory
Gas Exchange and Transport
Accelerators
The effectiveness of calcium chloride can...

